日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Acceptability and safety of one versus three months of rifapentine and isoniazid to prevent tuberculosis in people exposed in the household or workplace in Brazil: The Ultra-Curto randomized controlled trial

在巴西,针对家庭或工作场所结核病暴露人群,使用利福喷丁和异烟肼治疗一个月与三个月预防结核病的可接受性和安全性:Ultra-Curto随机对照试验

Durovni, Betina; Cordeiro-Santos, Marcelo; Cavalcante, Solange Cesar; Spener-Gomes, Renata; Garcia, Jamile; Cohn, Silvia; Saraceni, Valeria; Kohler, Beatriz; Moulton, Lawrence H; Brito da Souza, Alexandra; Berihun, Abiye; Marzinke, Mark; Chaisson, Richard E

Treatment completion and challenges in rolling out 12-dose weekly rifapentine plus isoniazid to prevent tuberculosis among people living with HIV and pediatric household contacts in Brazil

在巴西,针对艾滋病毒感染者及其儿童家庭接触者,推广每周12剂利福喷丁加异烟肼预防结核病的治疗完成情况及面临的挑战

Salles, Isadora; Oliveira, Jamile Garcia de; Souza, Alexandra Brito de; Cohn, Silvia; Spener-Gomes, Renata; Andrade, Solange Dourado de; Saraceni, Valeria; Cavalcante, Solange Cesar; Weiser, Jeff; Gombe, Makaita; Chihota, Violet; Churchyard, Gavin; Chaisson, Richard E; Cordeiro-Santos, Marcelo; Durovni, Betina

Cutaneous tuberculosis and HIV infection at a referral centre in Rio de Janeiro, Brazil

巴西里约热内卢一家转诊中心的皮肤结核病和艾滋病毒感染病例

Mann, Danielle; Sant'Anna, Flávia Marinho; Schmaltz, Carolina Arana Stanis; Freitas, Dayvison Francis Saraiva; Rolla, Valeria Cavalcanti; Cavalcante, Solange Cesar; Gutierrez-Galhardo, Maria Clara